首页> 外文期刊>Advances in Alzheimer's Disease >Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia
【24h】

Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia

机译:痴呆程度不同的阿尔茨海默氏病患者血浆中的同型半胱氨酸和不对称二甲基精氨酸浓度

获取原文
           

摘要

Alzheimer’s disease (AD) is accompanied by elevated levels of homocysteine (Hcy). Homocysteine may induce elevated concentration of asymmetric dimethylarginine (ADMA). Both Hcy and ADMA are the amino acids thought to represent risk factors of vascular diseases. Studies were conducted on the plasma levels of Hcy and methionine (Met), estimated by HPLC with electrochemical detection, as well as on levels of ADMA and arginine (Arg), estimated by HPLC with fluorescent detection, in the AD patients with benign through to severe dementia estimated by MMSE scale and in a control group. The studies disclosed elevated levels of Hcy and ADMA in AD (Hcy, p
机译:阿尔茨海默氏病(AD)伴随着高半胱氨酸(Hcy)水平升高。同型半胱氨酸可能会引起不对称二甲基精氨酸(ADMA)浓度升高。 Hcy和ADMA都是被认为代表血管疾病危险因素的氨基酸。在良性至良性至AD的AD患者中,对通过HPLC检测的Hcy和蛋氨酸(Met)的血浆水平进行了研究,以及通过HPLC进行了荧光检测的ADMA和精氨酸(Arg)的水平研究。通过MMSE量表和对照组评估为严重痴呆。研究发现AD中Hcy和ADMA的水平升高(Hcy,p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号